EFFICACY AND SAFETY OF SWITCHING FROM ADALIMUMAB TO SARILUMAB IN AN OPEN-LABEL EXTENSION OF A PHASE 3 MONOTHERAPY TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)

被引：0
|
作者：
Burmester, G. R. [1 ,2 ,3 ]
Fiore, S. [4 ]
Hu, C-C [4 ]
van Hoogstraten, H. [4 ]
Lee, Bong E. [5 ]
Genovese, M. C. [6 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Free Univ, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Sanofi Genzyme, Bridgewater, MA USA
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
[6] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
INTERNAL MEDICINE JOURNAL | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P33
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [41] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN A RHEUMATOID ARTHRITIS OPEN-LABEL EXTENSION STUDY FOLLOWING ADALIMUMAB THERAPY IN A PHASE 3 RANDOMISED CLINICAL TRIAL
    Genovese, M.
    van Vollenhoven, R.
    Wilkinson, B.
    Wang, L.
    Zwillich, S.
    Gruben, D.
    Benda, B.
    Jones, T.
    Bradley, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 65 - 65
  • [42] Tofacitinib, An Oral Janus Kinase Inhibitor, In A Rheumatoid Arthritis Open-Label Extension Study Following Adalimumab Therapy In A Phase 3 Randomised Clinical Trial
    Genovese, M. C.
    van Vollenhoven, R. F.
    Wilkinson, B.
    Wang, L.
    Zwillich, S. H.
    Gruben, D.
    Benda, B.
    Jones, T. V.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S190 - S191
  • [43] OPEN-LABEL TREATMENT OF RHEUMATOID-ARTHRITIS (RA) - EFFICACY AND TOLERABILITY OF NABUMETONE
    SPREKELER, R
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 164 - 164
  • [44] Garadacimab for hereditary angioedema prophylaxis: Efficacy and safety from a Phase 2 open-label extension trial
    Craig, T. J.
    Reshef, A.
    Lumry, W. R.
    Saguer, I. Martinez
    Jacobs, J. S.
    Yang, W. H.
    Aygoren-Pursun, E.
    Keith, P. K.
    Busse, P.
    Magerl, M.
    Feuersenger, H.
    Bica, M. A.
    Glassman, F.
    Pragst, I.
    Levy, D. S.
    ALLERGOLOGIE, 2023, 46 (08) : 560 - 561
  • [45] Impact of adalimumab on rheumatoid arthritis (RA) outcomes: Comparison of an open-label extension study and a registry-based control group
    Halpern, M. T.
    Citaldi, M.
    Kvien, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 171 - 171
  • [46] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [47] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    Arthritis Research & Therapy, 21
  • [48] Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
    Coates, Laura C.
    McInnes, Iain B.
    Merola, Joseph F.
    Warren, Richard B.
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Gossec, Laure
    Assudani, Deepak
    Bajracharya, Rajan
    Coarse, Jason
    Ink, Barbara
    Ritchlin, Christopher T.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1959 - 1970
  • [49] SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS WITH INADEQUATE RESPONSE TO TNF INHIBITORS
    Fleischmann, R.
    Hrycaj, P.
    van Hoogstraten, H.
    Mangan, E. K.
    Lin, Y.
    Jayawardena, S.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 853 - 853
  • [50] EFFICACY AND SAFETY OF SARILUMAB PLUS MTX IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN A PHASE 3 STUDY
    Kavanaugh, Arthur
    Kivitz, Alan J.
    Miranda, Pedro C.
    Fiore, Stefano
    Fay, Jonathan
    Fan, Chunpeng
    Van Adelsberg, Janet
    Huizinga, Tom W. J.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 42 - 42
12345